Symposia: Myeloid Oncogenesis: Basic
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Fundamental Science, Acute Myeloid Malignancies, AML, Translational Research, CHIP, genomics, hematopoiesis, Chronic Myeloid Malignancies, CMML, Diseases, Myeloid Malignancies, Biological Processes, Technology and Procedures, multi-systemic interactions, omics technologies
Type: Oral
Hematology Disease Topics & Pathways:
Research, Fundamental Science, Acute Myeloid Malignancies, AML, Translational Research, CHIP, genomics, hematopoiesis, Chronic Myeloid Malignancies, CMML, Diseases, Myeloid Malignancies, Biological Processes, Technology and Procedures, multi-systemic interactions, omics technologies
Monday, December 12, 2022: 2:45 PM-4:15 PM
293-294
(Ernest N. Morial Convention Center)
Moderators:
Daniel Herranz, PharmD, PhD, The Cancer Institute of New Jersey
and
Claudia Lengerke, MD, University Hospital Tuebingen
Disclosures:
No relevant conflicts of interest to declare.
Fundamental Research Relating to DNA Damage and Genetic Evolution in Myeloid Oncogenesis.
2:45 PM
3:00 PM
3:30 PM
3:45 PM
4:00 PM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH